FI962750A - Menetelmä neurogeenisen tulehduksen hoitamiseksi - Google Patents

Menetelmä neurogeenisen tulehduksen hoitamiseksi Download PDF

Info

Publication number
FI962750A
FI962750A FI962750A FI962750A FI962750A FI 962750 A FI962750 A FI 962750A FI 962750 A FI962750 A FI 962750A FI 962750 A FI962750 A FI 962750A FI 962750 A FI962750 A FI 962750A
Authority
FI
Finland
Prior art keywords
neurogenic inflammation
treating neurogenic
treating
inflammation
neurogenic
Prior art date
Application number
FI962750A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962750A0 (fi
Inventor
Knud Erik Andersen
Uffe Bang Olsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI962750A0 publication Critical patent/FI962750A0/fi
Publication of FI962750A publication Critical patent/FI962750A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI962750A 1994-01-04 1996-07-04 Menetelmä neurogeenisen tulehduksen hoitamiseksi FI962750A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK2094 1994-01-04
PCT/DK1995/000003 WO1995018615A1 (fr) 1994-01-04 1995-01-03 Procede de traitement de l'inflammation neurogene

Publications (2)

Publication Number Publication Date
FI962750A0 FI962750A0 (fi) 1996-07-04
FI962750A true FI962750A (fi) 1996-09-04

Family

ID=8088844

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962750A FI962750A (fi) 1994-01-04 1996-07-04 Menetelmä neurogeenisen tulehduksen hoitamiseksi

Country Status (13)

Country Link
EP (1) EP0735872A1 (fr)
JP (1) JPH09507849A (fr)
CN (1) CN1142183A (fr)
AU (1) AU1311195A (fr)
BR (1) BR9506453A (fr)
CA (1) CA2180239A1 (fr)
CZ (1) CZ198396A3 (fr)
FI (1) FI962750A (fr)
HU (1) HUT76281A (fr)
IL (1) IL112223A0 (fr)
NO (1) NO962812L (fr)
WO (1) WO1995018615A1 (fr)
ZA (1) ZA9530B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022342A1 (fr) * 1995-12-15 1997-06-26 Novo Nordisk A/S Nouveau procede
US7417040B2 (en) 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965639A (en) * 1960-12-20 New basically substituted azepine
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer

Also Published As

Publication number Publication date
FI962750A0 (fi) 1996-07-04
CN1142183A (zh) 1997-02-05
WO1995018615A1 (fr) 1995-07-13
EP0735872A1 (fr) 1996-10-09
ZA9530B (en) 1996-07-04
AU1311195A (en) 1995-08-01
CA2180239A1 (fr) 1995-07-13
IL112223A0 (en) 1995-03-30
HUT76281A (en) 1997-07-28
NO962812L (no) 1996-09-04
HU9601826D0 (en) 1996-09-30
NO962812D0 (no) 1996-07-03
CZ198396A3 (en) 1997-01-15
JPH09507849A (ja) 1997-08-12
BR9506453A (pt) 1997-09-02

Similar Documents

Publication Publication Date Title
FI963597A0 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
DE69534965D1 (de) Abscheidungsverfahren
DE69527353D1 (de) Beschichtungsverfahren und -vorrichtung
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
KR960012601A (ko) 원-직선편파변환기 및 그의 제조방법
DE69519583D1 (de) Schlammentwässerungsverfahren
DE69518183D1 (de) Beschichtungsvorrichtung und -verfahren
FI971884A0 (fi) Tietoliikennemenetelmä ja -järjestely
DE69526475D1 (de) 5-Alphareduktase-Inhibitoren
ID19570A (id) Metode merawat tanaman kotiledonous
FI973173A (fi) Menetelmä kondensaatin käsittelemiseksi
DK96392D0 (da) Modifikationsmetode
ITMI950393A0 (it) Metodo per il trattamento di piante
DE69717846D1 (de) Behandlungsverfahren von laktamen
ID18300A (id) Metoda penemperan
IS4285A (is) Aðferð við að hindra útfellingu
FI962750A0 (fi) Menetelmä neurogeenisen tulehduksen hoitamiseksi
FI960755A (fi) Menetelmä selluloosamateriaalin käsittelemiseksi
ID16924A (id) Metode perlakuan poliolefin
FI970098A (fi) Menetelmä ja yhdiste hiustenlähdön hoitamiseksi
UA25349A (uk) Спосіб лікуваhhя гострого деструктивhого паhкреатиту
UA25464A (uk) Спосіб лікуваhhя гострого пієлоhефриту
UA24720A (uk) Спосіб алотраhсплаhтації hирки
UA25110A (uk) Спосіб біліосорбції

Legal Events

Date Code Title Description
FD Application lapsed